Acadian Asset Management LLC Instil Bio, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.4 - $0.63 $49,540 - $78,025
123,850 Added 32.56%
504,268 $214,000
Q2 2023

Aug 07, 2023
BUY
$0.51 - $0.67 $157,527 - $206,948
308,878 Added 431.76%
380,418 $208,000
Q1 2023

May 11, 2023
SELL
$0.6 - $0.91 $231,016 - $350,374
-385,027 Reduced 84.33%
71,540 $47,000
Q4 2022

Feb 14, 2023
BUY
$0.48 - $5.33 $219,152 - $2.43 Million
456,567 New
456,567 $287,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.57B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email